Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase. See why I rate HIMS stock a ...

The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...

The U.S. stock market was down for the week despite a positive Friday, as tariff developments from the Trump administration ...

We recently published a list of Jim Cramer Commented On These 6 Stocks Recently. In this article, we are going to take a look ...

What's considered excellent revenue growth depends on the industry. With that context in mind, consider that Eli Lilly's ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Compounders had been allowed to produce and sell hundreds of thousands of their own versions of popular anti-obesity drugs, ...

As earnings season begins, filings to the SEC point to uncertainty from the current administration as potential trouble for ...

Novo Nordisk says many Australians would be willing to pay the out-of-pocket costs for its blockbuster medicines, which can ...